Literature DB >> 17628765

[Chronic renal failure and transplantation].

U Kunzendorf1, L Renders, E Ziegler.   

Abstract

Kidney transplantation is the best option for all patients with terminal renal failure. Kidney transplantation is not only associated with an improved quality of life in comparison to all other renal replacement therapies, this method also offers a significantly extended lifespan. Therefore, the option for transplantation has to be verified for every patient with renal failure. Graft and patient survival is best when transplantation is carried out just before starting dialysis treatment. Realistically, only living donor transplantation offers the option of sparing the recipient a long waiting period on dialysis. Although transplantation from living donors is superior to cadaveric kidney transplantation, a small risk remains for the donor. Kidney transplantation and the immunosuppressive therapy are associated with an increased risk for certain types of infection, an increased tumour risk and an increased risk for cardiovascular complications. To address these problems, specific recommendations for patient surveillance have been provided by different transplantation societies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628765     DOI: 10.1007/s00108-007-1889-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

Review 1.  Strategies to improve long-term outcomes after renal transplantation.

Authors:  Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  The evaluation of renal transplantation candidates: clinical practice guidelines.

Authors:  Bertram L Kasiske; Charles B Cangro; Sundaram Hariharan; Dondald E Hricik; Ronald H Kerman; David Roth; David N Rush; Miguel A Vazquez; Matthew R Weir
Journal:  Am J Transplant       Date:  2001       Impact factor: 8.086

3.  Living kidney donation and hypertension risk.

Authors:  Thai Nguyen; Miguel Vazquez; Robert Toto
Journal:  Lancet       Date:  2007-01-13       Impact factor: 79.321

4.  Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Richard J Howard; Shiro Fujita; Bruce Kaplan
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

5.  Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

Authors:  B L Kasiske; M A Vazquez; W E Harmon; R S Brown; G M Danovitch; R S Gaston; D Roth; J D Scandling; G G Singer
Journal:  J Am Soc Nephrol       Date:  2000-10       Impact factor: 10.121

Review 6.  Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression.

Authors:  A X Garg; N Muirhead; G Knoll; R C Yang; G V R Prasad; H Thiessen-Philbrook; M P Rosas-Arellano; A Housawi; N Boudville
Journal:  Kidney Int       Date:  2006-09-27       Impact factor: 10.612

7.  Impact of cadaveric renal transplantation on survival in patients listed for transplantation.

Authors:  Gabriel C Oniscu; Helen Brown; John L R Forsythe
Journal:  J Am Soc Nephrol       Date:  2005-04-27       Impact factor: 10.121

8.  Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.

Authors:  Daniel Abramowicz; Maria Del Carmen Rial; Stefan Vitko; Domingo del Castillo; Derek Manas; Mieczyslaw Lao; Nesrin Gafner; Peter Wijngaard
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

9.  The long-term consequences of living-related or unrelated kidney donation.

Authors:  Claudia Sommerer; Christian Morath; Joachim Andrassy; Martin Zeier
Journal:  Nephrol Dial Transplant       Date:  2004-07       Impact factor: 5.992

10.  Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus.

Authors:  T S Larson; P G Dean; M D Stegall; M D Griffin; S C Textor; T R Schwab; J M Gloor; F G Cosio; W J Lund; W K Kremers; S L Nyberg; M B Ishitani; M Prieto; J A Velosa
Journal:  Am J Transplant       Date:  2006-03       Impact factor: 8.086

  10 in total
  1 in total

1.  [Terminal renal insufficiency and indication for kidney transplantation].

Authors:  C Protzel; A Führer; O W Hakenberg
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.